Oral cyclic megadose methylprednisolone therapy for chronic immune thrombocytopenic purpura in childhood

European Journal of Haematology

Volumn 64, Issue 6, 2000, Pages 411-415

  Özer, Esra Arun ^a,c   Yaprak, Işin ^a   Atabay, Berna ^a   Türker, Meral ^a   Akşit, Sadik ^b   Sarioǧlu, Berrak ^a  

^a SSK Tepecik Teaching Hospital   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Chronic ITP; Methylprednisolone; Platelet

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 0033933684     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90166.x     Document Type: Article

References (14)

1. 1. BERADSLEY DS. Platelet abnormalities in infancy and childhood. In: NATHAN DG, OSKI FA, eds. Hematology of Infancy and Childhood, 4th edn. Philadelphia: WB Saunders, 1992:1561-1604.
2. 2. MEDEIROS D, BUCHANAN GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatr Clin North Am 1996;43:757-772.
3. 3. GEORGE JN, WOOLF SH, RASKOB GE, WASSER JS, ALEDORT LM, BALLEM PJ, BLANCHE VS, BUSSEL JB, CINES DB, KELTON JG, LICHTIN AE, MCMILLAN R, OKERBLOOM JA, REGAN DH, WARRIER I. Idiopathic thrombocytopenic purpura: A practice guideline developed by expicit methods for the American Society of Hematology. Blood 1996;88:3-40.
4. 4. VANHOFF J, RITCHEY AK. Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. J Pediatr 1988;113:563-566.
5. 5. ÖZSOYLU S. High-dose intravenous methylprednisolone for chronic idiopathic thrombocytopenic purpura. Acta Haematol 1989;81:112-113.
6. 6. BORGNA-PIGNATTI C, RUGOLOTTO S, NOBILI B, AMENDOLA G, DE STEFANO P, MACCARIO R, LOCATELLI F. A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr 1997;130: 13-16.
7. 7. ANDERSEN JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994;330:1560-1564.
8. 8. KÜHNE T, FREEDMAN J, SEMPLE JW, DOYLE J, BUTCHART S, BLANCHETTE VS. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997;130:17-24.
9. 9. BLANCHETTE VS, KIRBY MA, TURNER C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol 1992;29:72-82.
10. 10. YAPRAK I, CAGLAYAN S, KANSOY S, OZDOGRU E, BAKILER AR, AYDINLIOGLU H. Long-term use of anti-D in chronic idiopathic thrombocytopenic purpura. Turk J Pediatr 1994;36: 43-47.
11. 11. WARNER M, WASI P, COUBAN S, HAYWARD C, WARKENTIN T, KELTON JG. Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopenia. Am J Hematol 1997;54:267-270.
12. 12. CAULIER MT, ROSE C, ROUSSEL MT, HUART C, BAUTERS F, FENAUX P. Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases. Br J Haematol 1995;91:477-479.
13. 13. OZSOYLU S, SAYLI TR, OZTURK G. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1993;10:317-321.
14. 14. ALBAYRAK D, ISLEK I, KALAYCI AG, GURSES N. Acute immune thrombocytopenic purpura: a comperative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr 1994;125: 1004-1007.